1. Home
  2. EPR vs GPCR Comparison

EPR vs GPCR Comparison

Compare EPR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPR Properties

EPR

EPR Properties

N/A

Current Price

$55.52

Market Cap

4.6B

Sector

Real Estate

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$29.29

Market Cap

3.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EPR
GPCR
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.8B
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
EPR
GPCR
Price
$55.52
$29.29
Analyst Decision
Hold
Strong Buy
Analyst Count
12
16
Target Price
$64.68
★ $105.78
AVG Volume (30 Days)
788.1K
★ 1.2M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 6.59%
N/A
EPS Growth
★ 105.00
N/A
EPS
★ 1.53
N/A
Revenue
★ $718,357,000.00
N/A
Revenue This Year
$9.58
N/A
Revenue Next Year
$6.44
N/A
P/E Ratio
$36.27
★ N/A
Revenue Growth
★ 2.91
N/A
52 Week Low
$48.11
$25.59
52 Week High
$64.97
$94.90

Technical Indicators

Market Signals
Indicator
EPR
GPCR
Relative Strength Index (RSI) 27.87 21.44
Support Level $49.01 N/A
Resistance Level $56.03 $56.63
Average True Range (ATR) 1.05 1.79
MACD -0.14 -0.27
Stochastic Oscillator 0.00 7.79

Price Performance

Historical Comparison
EPR
GPCR

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: